Bioequivalence Study of Ramipril 10 mg Capsules Under Fasting Conditions
- First Posted Date
- 2009-04-10
- Last Posted Date
- 2009-04-10
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 68
- Registration Number
- NCT00879476
- Locations
- 🇮🇳
Ranbaxy Clinical Pharmacology Unit, Ranbaxy Laboratories Limited, Noida, Uttar Pradesh, India
Bioequivalence Study of Ramipril 10 mg Capsules Under Fed Conditions
- First Posted Date
- 2009-04-10
- Last Posted Date
- 2009-04-10
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT00879788
- Locations
- 🇮🇳
Clinical Pharmacology Unit, Majeedia Hospital (2nd Floor), New Delhi, India
Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-03-31
- Last Posted Date
- 2009-03-31
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00872235
- Locations
- 🇮🇳
Ranbaxy CPU, New Delhi, India
Bioequivalence Study of Sumatriptan 100mg Tablets Under Fasting Conditions
- First Posted Date
- 2009-03-31
- Last Posted Date
- 2009-03-31
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT00872924
- Locations
- 🇮🇳
Ranbaxy CPU, Noida,, Uttar Pradesh, India
Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-03-31
- Last Posted Date
- 2009-03-31
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 64
- Registration Number
- NCT00872781
- Locations
- 🇮🇳
Ranbaxy Clinical Pharmacology Unit, Noida,, Uttar Pradesh, India
Bioequivalence Study of Sumatriptan 100mg Tablets Under Fed Conditions
- First Posted Date
- 2009-03-31
- Last Posted Date
- 2009-03-31
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT00872274
- Locations
- 🇮🇳
Ranbaxy CPU, Noida,, Uttar Pradesh, India
Bioequivalence Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fed Conditions
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-18
- Last Posted Date
- 2009-02-18
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00845546
- Locations
- 🇨🇦
MDS Pharma Services, St. Laurent, Quebec, Canada
Bioequivalnce Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-06
- Last Posted Date
- 2009-02-06
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00837915
- Locations
- 🇨🇦
MDS Pharma Services, Montreal, Quebec, Canada
Bioequivalence Study of Zolpidem 10 mg Tablets Under Fed Conditions
- First Posted Date
- 2008-10-24
- Last Posted Date
- 2008-10-24
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 36
- Registration Number
- NCT00779441
- Locations
- 🇺🇸
PRACS Institute Ltd., Fargo, North Dakota, United States
Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fed Conditions
- First Posted Date
- 2008-10-24
- Last Posted Date
- 2008-10-24
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 36
- Registration Number
- NCT00778973
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Pittsburgh,, Pennsylvania, United States
© Copyright 2024. All Rights Reserved by MedPath